“De Novo Design and Molecular Dynamics Evaluation of AZ67-Derived Allosteric PFKFB3 Modulators for Anticancer Metabolic Drug Discovery” (2026) Journal of Cancer Research Updates, 15(3), pp. 249–261. doi:10.30683/1929-2279.2026.15.23.